Latest Articles
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post
Published: Jan. 12, 2026, 6:10 p.m.
‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet
‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment SurvivorNet
Published: Jan. 11, 2026, 6:06 p.m.
Endometriosis Treatment Market Forecast to Grow to USD 3.37 - openPR.com
Endometriosis Treatment Market Forecast to Grow to USD 3.37 openPR.com
Published: Jan. 9, 2026, 10:57 a.m.
Endogene.bio Research Identifies Molecular Subtypes in Endometriosis That Could Guide Treatment Selection - Femtech Insider
Endogene.bio Research Identifies Molecular Subtypes in Endometriosis That Could Guide Treatment Selection Femtech Insider
Published: Jan. 8, 2026, 6:02 a.m.
Patient-Derived Endometrium Chip Aims to Personalize Infertility Treatment - 동아사이언스
Patient-Derived Endometrium Chip Aims to Personalize Infertility Treatment 동아사이언스
Published: Jan. 6, 2026, 8:26 a.m.
Study Explores Role of Fibrosis in Impaired Ovarian Function and Potential Use of Pirfenidone for Endometriosis Treatment - geneonline.com
Study Explores Role of Fibrosis in Impaired Ovarian Function and Potential Use of Pirfenidone for Endometriosis Treatment geneonline.com
Published: Jan. 5, 2026, 9:43 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - BIOENGINEER.ORG
Pirfenidone’s Promise for Ovarian Endometriosis Treatment BIOENGINEER.ORG
Published: Jan. 5, 2026, 8:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - Bioengineer.org
Pirfenidone’s Promise for Ovarian Endometriosis Treatment Bioengineer.org
Published: Jan. 5, 2026, 8:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - bioengineer.org
Pirfenidone’s Promise for Ovarian Endometriosis Treatment bioengineer.org
Published: Jan. 5, 2026, 8:34 p.m.
Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab - OncLive
Endometrial Cancer: Toxicity Management and Treatment Persistence with Lenvatinib-Pembrolizumab OncLive
Published: Dec. 26, 2025, 1:19 p.m.
Link copied to clipboard!